Research

Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control


Reference:

Reid, J., Lawrence, J. M., Taylor, G. J., Stirling, C. A. and Reckless, J. P. D., 2006. Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control. Atherosclerosis Supplements, 7 (3), p. 330.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below.

Details

Item Type Articles
CreatorsReid, J., Lawrence, J. M., Taylor, G. J., Stirling, C. A. and Reckless, J. P. D.
DepartmentsFaculty of Humanities & Social Sciences > Health
RefereedYes
StatusPublished
ID Code6396
Additional InformationID number: ISI:000239093902096

Export

Actions (login required)

View Item